Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study in PAH Patients - Slideshow (NASDAQ:INSM) 2026-07-16

Summary by Seeking Alpha
2026-07-16. The following slide deck was published by Insmed Incorporated in conjunction with this event.

2 Articles

Seeking AlphaSeeking Alpha
Lean Right

Insmed Incorporated (INSM) Discusses 12-Month Results From Ongoing TPIP Open-Label Extension Study in PAH Patients - Slideshow (NASDAQ:INSM) 2026-07-16

2026-07-16. The following slide deck was published by Insmed Incorporated in conjunction with this event.

·Ra'anana, Israel
Read Full Article
stocktitan.netstocktitan.net

Insmed Announces Positive 12-Month Data from the Ongoing Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Patients with Pulmonary Arterial Hypertension

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources lean Right
100% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

stocktitan.net broke the news on Thursday, July 16, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Bridgewater icon

Bridgewater

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal